Dr. Derek S Gilchrist, Co-Founder and Chief Executive Officer
Derek is a biomedical research scientist with 18 years of molecular biology experience and graduate from INSEAD’s Entrepreneurs in Clinical Academia Course and MIT’s Entrepreneurship Development
Mr. Neal L Millar, Co-Founder and Chief Medical Officer
Neal is an Academic Consultant Orthopaedic Surgeon specialising in shoulder surgery having completed fellowships in Sydney and New York and is an expert in human tendinopathy.
Dr. Declan Doogan , Chairman
Declan is Chairman of BiohavenPharmaceuticals, CEO of Portage Biotech. He has more than 30 years of pharmaceutical industry experience spanning numerous roles including Chairman of Spinifex Pharmaceuticals, Chief Medical Officer at AmarinCorporation and Senior Vice President and Head of World Development at Pfizer.
Mr. David Armour, Chief Financial Officer .
David is an experienced CFO, specialising in working with entrepreneurial, owner-managed companies. Previously worked in venture capital as co-founder of PentechVentures, the UK's leading early stage technology fund.
Dr. Neil Gibson, Non Exec Director
Dr brings more than 25 years of drug development experience to Causeway including chief scientific officer at microRNA company Regulus Therapeutics; involved in the initial public offering for Regulus Therapeutics, which raised an initial $80.9 million and subsequent follow on financings of about $105 million.
Mr. Chris Jones, Non Exec Director
Chris brings 25 years of success leading new medical products from concept through to market adoption in VC and Fortune 500 companies, currently Chairman of Mologic, and NED for Deltex Medical, MediSieve and Health Enterprise East and has raised over $40 M in funding from Venture, Corporate and Angel investors.
Prof. Neal Juster, Non Exec Director
Neal Neal Juster is currently Vice-Principal (Strategy and Resources) at The University of Glasgow, a role he has held since August 2007.He is a Trustee of the University of Glasgow Trust and the University of Glasgow Pension Fund. He is also a Director of Glasgow University Holdings Limited and Systems Level Integration Limited.
Prof. Iain B McInnes, Lead Medical Advisor
Iain is Director of the Institute of Infection, Immunity and Inflammation in the University of Glasgow. Iain has extensive interaction with the pharmaceutical industry and sits on the advisory boards of Pfizer; BMS; AstraZeneca; Janssen; Novartis and NovoNordisk.
Susan Kitson, Chief Research Officer
Susan has over 25 years of experience in the Life Science sector gained in an academic and industrial CRO setting where she tested novel anti-inflammatory drugs in vitro along with antibody production.
Derek is a biomedical research scientist with 18 years of molecular biology experience and graduate from INSEAD’s Entrepreneurs in Clinical Academia Course and MIT’s Entrepreneurship Development
Mr. Neal L Millar, Co-Founder and Chief Medical Officer
Neal is an Academic Consultant Orthopaedic Surgeon specialising in shoulder surgery having completed fellowships in Sydney and New York and is an expert in human tendinopathy.
Dr. Declan Doogan , Chairman
Declan is Chairman of BiohavenPharmaceuticals, CEO of Portage Biotech. He has more than 30 years of pharmaceutical industry experience spanning numerous roles including Chairman of Spinifex Pharmaceuticals, Chief Medical Officer at AmarinCorporation and Senior Vice President and Head of World Development at Pfizer.
Mr. David Armour, Chief Financial Officer .
David is an experienced CFO, specialising in working with entrepreneurial, owner-managed companies. Previously worked in venture capital as co-founder of PentechVentures, the UK's leading early stage technology fund.
Dr. Neil Gibson, Non Exec Director
Dr brings more than 25 years of drug development experience to Causeway including chief scientific officer at microRNA company Regulus Therapeutics; involved in the initial public offering for Regulus Therapeutics, which raised an initial $80.9 million and subsequent follow on financings of about $105 million.
Mr. Chris Jones, Non Exec Director
Chris brings 25 years of success leading new medical products from concept through to market adoption in VC and Fortune 500 companies, currently Chairman of Mologic, and NED for Deltex Medical, MediSieve and Health Enterprise East and has raised over $40 M in funding from Venture, Corporate and Angel investors.
Prof. Neal Juster, Non Exec Director
Neal Neal Juster is currently Vice-Principal (Strategy and Resources) at The University of Glasgow, a role he has held since August 2007.He is a Trustee of the University of Glasgow Trust and the University of Glasgow Pension Fund. He is also a Director of Glasgow University Holdings Limited and Systems Level Integration Limited.
Prof. Iain B McInnes, Lead Medical Advisor
Iain is Director of the Institute of Infection, Immunity and Inflammation in the University of Glasgow. Iain has extensive interaction with the pharmaceutical industry and sits on the advisory boards of Pfizer; BMS; AstraZeneca; Janssen; Novartis and NovoNordisk.
Susan Kitson, Chief Research Officer
Susan has over 25 years of experience in the Life Science sector gained in an academic and industrial CRO setting where she tested novel anti-inflammatory drugs in vitro along with antibody production.